Sources | Names Used |
---|---|
CTRPv2 | YL54 |
PharmacoGx | YL54 |
Database | Identifier |
---|---|
Smiles: | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCCC=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IDO2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF385C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | KIR3DX1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ACP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | C17orf105 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ZFP69B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | FCMR | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | C4orf32 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | KRTAP5-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PPP1R13B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |